Toggle navigation
Home
Search
Services
Blog
Contact
About
Diagnostics to Enable Neglected Tropical Diseases (NTDs) Elimination
Glucosentient, Inc., Champaign, IL, United States
Search grants from Glucosentient, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
Molecular Genetics of Midline Glial Development
Anoxia Responsive VL30 Elements
Liposome Microencapsulation of Vaccine Antigens
Regulation of Mrna Abundance
Recently added grants:
A novel approach to study pain in a mouse model of facial burn injury
PERU Clinical Trial Unit
The role of beta-catenin in the pathophysiology of infantile spasms
Defining Direct and Indirect Roles of Nodal Signaling in Convergence & Extension
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201800054C-0-0-1
Application #
9791233
Study Section
Project Start
2018-09-28
Project End
2021-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2018
Total Cost
Indirect Cost
Institution
Name
Glucosentient, Inc.
Department
Type
DUNS #
078305396
City
Champaign
State
IL
Country
United States
Zip Code
61820
Comments
Be the first to comment on this grant
